1. The plaintiff's claim against the defendants is dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

1. Facts of recognition;

A. Defendant C is the representative director of the Company D (hereinafter “instant Company”), and Defendant B is the managing director of the said Company.

B. The Defendants introduced that they can completely recover cancer with the stem cell back of Japan by approaching cancer patients even though they were not doctors, and subsequently conspired to collect blood from cancer patients and send them to the above internal department, and then to provide treatment again for injection to the blood transfusion of cancer patients after receiving the blood from the above internal department.

Accordingly, on April 30, 2013, Defendant B said, “C Co., Ltd. is a Korean office of the Japanese hospital and the Japanese hospital” to the Plaintiff’s husband F, who was administered in the Gandong Hospital on the end of April 30, 2013, that Defendant B completely recovers from the terminal cancer patients who fall short of the absolute condition at the Korean hospital for treatment of stem cell white, and the medical treatment rate is at least 70%. The president was able to live in her country. The method of treating the patient was that he collected the blood, sent the recovered blood to the Japanese E, and made her back the her back to the patient.”

C. Since May 13, 2013, the Plaintiff returned to the Defendants’ office with her husband F around May 13, 2013, and the said F entered the Defendant’s office with the instant company as the subscription amounting to KRW 66 million between the Defendant and the Defendant. The deposit method is KRW 10 million on May 14, 2013, and the deposit method is KRW 10 million.

5.28.26 million won, and the same year.

6. On November 3, 2011, an offer was made by setting forth a KRW 30 million and preparing an offer, and deposited KRW 10 million on May 14, 2013, and KRW 26 million on May 28, 2013, and KRW 36 million in total in the account under the name of the said company.

Since then, the instant company collected F blood from Japan and sent them to Japan, received cancer treatment chemicals produced by using the above blood from the above internal department, and Defendant B performed three times the above cancer treatment chemicals to F’s blood center from May 28, 2013, but F died on June 16, 2013.

E. Afterward, the Plaintiff.